Senior Principal Scientist, Patient Centered Endpoints, IQVIA
Harnessing Patient-Centered Science to Improve Health Outcomes and Commercial Pharma Success
Good scientific principles and practices are essential for maintaining quality data that patients can benefit from.
Therapeutic Success or Failure: A Journey, Not Just a Destination
Measuring clinically relevant response requires routine and regular collection of outcomes data.
Patient’s Voice Finally Being Heard in Diabetes Drug Research
Combining PRO data with clinical feasibility data can make a difference in diabetes care.
The Patient’s Voice is Finally Being Heard in Diabetes Drug Research
Type 2 diabetes mellitus is one of the Western world’s most common chronic conditions, with global prevalence increasing rapidly.
Patient Perspective Plays Important Role in Development of New Diabetes Treatment
Trulicity® (dulaglutide), approved by the EMA in November 2014 for the treatment of Type 2 diabetes in adults, is the first diabetes drug to have a Patient Reported Outcome.
2 Clarke Drive Cranbury, NJ 08512